Page last updated: 2024-11-06

tryptophan ethyl ester

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tryptophan ethyl ester (TEE) is a derivative of the essential amino acid tryptophan. It is synthesized by reacting tryptophan with ethanol in the presence of an acid catalyst. TEE is a promising drug candidate due to its ability to cross the blood-brain barrier and its potential to enhance cognitive function and reduce anxiety. Studies have shown that TEE can improve memory, learning, and mood in animal models. The mechanism by which TEE exerts these effects is thought to involve modulation of neurotransmitter systems, particularly serotonin and dopamine. TEE is being studied for its potential therapeutic benefits in conditions such as Alzheimer's disease, depression, and anxiety. However, further research is needed to fully understand its safety and efficacy in humans.'

tryptophan ethyl ester: RN given refers to (DL)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID81996
CHEMBL ID54665
SCHEMBL ID133958
MeSH IDM0084220

Synonyms (17)

Synonym
einecs 231-285-1
67645-67-4
MAYBRIDGE1_006127
ethyl l-tryptophanate
CHEMBL54665
l-tryptophan ethyl ester
ethyl (2s)-2-amino-3-(1h-indol-3-yl)propanoate
tryptophan ethyl ester
dl-tryptophan, ethyl ester
SCHEMBL133958
racemic tryptophan ethyl ester
tryptophan, ethyl ester, l-
AKOS030213049
tryptophan ethylester
(s)-ethyl 2-amino-3-(1h-indol-3-yl)propanoate
DTXSID00884387
EN300-6511483
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID724510Antimicrobial activity against Staphylococcus aureus ATCC 65382013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Synthesis and evaluation of novel sulfenamides as novel anti Methicillin-resistant Staphylococcus aureus agents.
AID724316Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate 309-42013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Synthesis and evaluation of novel sulfenamides as novel anti Methicillin-resistant Staphylococcus aureus agents.
AID724313Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate 309-82013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Synthesis and evaluation of novel sulfenamides as novel anti Methicillin-resistant Staphylococcus aureus agents.
AID724315Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate 6-422013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Synthesis and evaluation of novel sulfenamides as novel anti Methicillin-resistant Staphylococcus aureus agents.
AID724314Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate 309-72013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Synthesis and evaluation of novel sulfenamides as novel anti Methicillin-resistant Staphylococcus aureus agents.
AID724508Antimicrobial activity against methicillin-sensitive Staphylococcus aureus isolate 309-12013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Synthesis and evaluation of novel sulfenamides as novel anti Methicillin-resistant Staphylococcus aureus agents.
AID724317Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate Chaoyang2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Synthesis and evaluation of novel sulfenamides as novel anti Methicillin-resistant Staphylococcus aureus agents.
AID26797Partition coefficient (logP)1987Journal of medicinal chemistry, Oct, Volume: 30, Issue:10
Quantitative structure-activity relationships of the bitter thresholds of amino acids, peptides, and their derivatives.
AID233318Bitter threshold value1987Journal of medicinal chemistry, Oct, Volume: 30, Issue:10
Quantitative structure-activity relationships of the bitter thresholds of amino acids, peptides, and their derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (41.67)18.7374
1990's2 (8.33)18.2507
2000's3 (12.50)29.6817
2010's6 (25.00)24.3611
2020's3 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.90 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (4.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (96.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]